fda tirzepatide Grants a New Indication for Obesity Management FDA says the tirzepatide weight-loss

Automated data-adaptive analytics for electronic healthcare data to study causal treatment effects

Multiple studies have demonstrated that infant exposure through breast milk is clinically insignificant, with no adverse effects reported

Food and Drug Administration (FDA) approved Semaglutide under the brand name Ozempic for the treatment of type 2 diabetes

Cushing syndrome in the McCune-Albright syndrome

parkeri peptidoglycan remodeling via a cysteine requirement of periplasmic proteins such as autolysins, or via a specific role for cysteine in regulating autolysin gene expression, which will require further investigation

L- (ABPI) L- , (, , )